04/23/2024
3:05 PM | Aptevo Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:10 PM | Aptevo Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:15 PM | Aptevo Therapeutics (Filer)
| Form ARS | |
04/12/2024
4:23 PM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
04/10/2024
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
04/09/2024
4:26 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/29/2024
4:00 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
|
03/20/2024
3:15 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/07/2024
7:56 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:24 PM | Aptevo Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/06/2024
3:37 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
5:02 PM | Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:04 PM | Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:05 PM | Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:00 AM | Aptevo Therapeutics (Filer)
| Form DEFR14A | |
12/12/2023
3:19 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
11/30/2023
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
11/09/2023
4:17 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:41 AM | Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:44 AM | Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:47 AM | Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:16 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
08/01/2023
3:01 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
07/18/2023
7:16 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
3:16 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
06/30/2023
3:16 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/11/2023
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:31 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
